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Cytotoxic Tlymphocytes(CTL)use class I molecules ofthe MHC in the recogni-
tion of virally infected and foreign cells (reviewed in reference 1). It has recently
been demonstrated that class I molecules can present specific peptide fragments de-
rived from processed antigens toinfluenzavirus-specificCTL (2), andto H-2-restricted
CTL specific for HLAantigens expressed in murine transfectants(3). These results
suggested that CTL specific for alloantigens and xenoantigens might also recognize
epitopes composed ofMHC antigens together with peptides derived fromthe target
cell. It hasbeenshownthat CTL clones raised against HLA-A2 onhuman cells often
did not recognize the same antigen expressed on murine transfectants (4-10), and
evidence was obtained that suggested this might be due to a difference in the epi-
topesassociatedwith HLA-A2.1 on human and murine cells(11). This has now been
investigated directly using transgenic mice that express the human HLA-A2.1 an-
tigen. Although these mice were tolerant to HLA-A2.1+ murine cells, specific CTL
responses were elicitedby HLA-A2.1 expressedonhuman cells. Theseresults strongly
suggest that proteins thatdiffer between mouse and human cells, but are highly con-
served amongmany differenthuman tissues, contribute to the formationofepitopes
recognized by class I MHC-specific CTL.
Cells.
￿
Lymphoid cells werecultured in RPMI 1640 medium, andnonlymphoid cells were
cultured in a MEM (Hazelton Research Products, Denver, PA), both supplemented with
2 mM glutamine and 107o FCS. Transfected cells were maintained in the presence of 250
gg/ml geneticin(Gibco Laboratories, Grand Island, NY) withthe exceptionofthe Ml trans-
fectants, which were maintained in 25 gg/ml mycophenolic acid. The expression of HLA-
A2.1 by allappropriate cells wasverified by flow cytometryusingthe HLA-A2-specific mAb
MA2.1 (12).
CTLclones werederivedbylimiting dilution culture ofspleen cellsfrom HLA-A2.1 trans-
genic or normal C57BL/6 mice immunized with 2 x 107 JY cells (HLA-A2; B7; DR4,6),
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as previously described (13). CTL clones were also derived from HLA-A2 transgenic mice
by limiting dilution cloning aftersecondary in vitro restimulation with JY CTL clones were
maintained as described (14).
"Cr ReleaseAssays.
￿
Assays were carried out for 4 h as described previously (14). The ex-
change of endogenous class I-associated 02m on target cells was accomplished by washing
cells three times in serum-free RPMI 1640 with subsequent culture for 14 h in the presence
of 10% human serum.
Results
HLA-A2 .1-expressing transgenic mice were produced from the C57BL/6 strain.
The expression of the HLA-A2.1 molecule on the surface of lymphoid cells from
these mice was determined to be approximately equal to that of H-2D6 (Le, A. T,
E. J. Bernhard, M. J. Holterman, P. Parham, E. Lacy, and V. H. Engelhard, sub-
mitted for publication). HLA-A2.1 transgenic and normal C57BL/6 mice were primed
in vivo with the HLA-A2.1 expressing human cell line, JY 1 mo later, spleen cells
from these animals were restimulated in limiting dilution microcultures with JY
cells. The lytic activity of these cultures was assessed using the HLA-A2.1-positive
human cell line HSB, and EL4-A2, a derivative of the syngeneic murine EL4 cell
line transfected with the gene for HLA-A2.1. CTL from normal C57BL/6 animals
showed a distribution ofreactivities ranging from exclusive recognition ofthe human
cell line to recognition of both mouse and human targets at comparable levels (Fig.
1 A). In contrast, no CTL from HLA-A2.1 transgenic animals that lysed the human
target showed significant reactivity on EL4-A2 (Fig. 1 B).
To characterize the epitopes recognized by CTL from the HLA-A2.1 transgenic
animals, 20 independent clones were derived from limiting dilution culture. Three
additionalclones were obtained from limiting dilution cloning of a secondary mixed
lymphocyte culture. All clones lysed the HLA-A2 .1-positive EBVtransformed B lym-
phoblastoid cell lines 23 .1, 310.B27#4, and the human HLA-A2 .1 transfectant LA2.1
(Table I). However, none of the clones lysed: HMY2 .ClR, the HLA-A2-negative
cell from which LA2 .1 was derived; MST, JM, and Daudi, which share MHC an-
tigens other than HLA-A2.1 with JY; or WT49 and DKlB, which express HLA-
A2.2 and -A2.3, respectively. All clones exhibited high levels of lysis on normal human
HLA-A2.1-positive PBL (Table I). These clones have been shown to recognize at
least four different epitopes (14a) . Taken together, these results indicate that these
FIGURE 1.
￿
Clonal reactivity pat-
terns from a C57BL/6 (A) or an
HLA-A2 transgenic (B) mouse
using human (HSB) and murine
(EL4-A2) target cells expressing
HLA-A2.1. The data shown are de-
rived from plates in which >37%
ofwells were negative for HLA-A2
reactivity.BERNHARD ET AL.
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TABLE I
CTL Clones from HLA-A2.1 Transgenic Mice Recognize
HLA-A2.1 Expressed on both Transformed and Non-transformed
Human Lymphoid Cells
23 CTL clones were assayed at an E/T ratio of 10:1 . Target cells include the B
lymphoblastoid cell lines 23.1 (HLA-A2;B27 ;DR8), 310.B27#4 (HLA-A2; B- ;
DR1,3), LA2 .1, an HLA-A2.1-expressing cell line derived from HMY2.CIR
(HLA-A- ; B- ; DR8) by electroporation, WT49 (HLA-A2.2; B17; DR3),
DKIB (HLA-A2.3,33; B40,44; DR6,-), MST (HLA-A3 ; B7 ; DR2), DAUDI
(HLA class I- ; DR6); the T lymphoblastoid lineJM (HLA-A3,25; B7,37); and
PBL, 3-d PHA (Gibco Laboratories) -stimulated normal PBLs from donor TJM
(HLA-A2,24; B7,62; C3,7; DR1,2) .
CTL are specific for several differentepitopes found on bothnormal and transformed
HLA-A2.1-positive human lymphoid cells.
The expression ofthe epitopes recognized by these CTL was further investigated
usingHLA-A2.1-positive cells derivedfromnonlymphoidtissue. Allofthe CTL clones
lysed RDA2, an HLA-A2-expressing transfectant ofthe humanrhabdomyosarcoma
cell line RD, and MIA2.1, an HLA-A2.1-expressing transfectant ofthe xeroderma
pigmentosumfibroblast Ml (Table II). All clones also lysed two HLA-A2-expressing
primary fibroblast lines, GM126 and GM2708. The HLA-A2-expressing osteosar-
coma cell line 143bTK- was lysed by only 17 of 22 clones tested, although it ex-
pressed HLA-A2 at levels comparable with RDA2 and GM2708. Only three of the
clones were able tolyseCVlP5A2, an HLA-A2.1-expressing transfectantoftheAfrican
greenmonkey cell lineCV1. None ofthe clones lysed HLA-A2.1-expressingmurine
transfectants derived from EL4 (Table II), the C127 mammary carcinoma, or the
P815 mastocytoma (data not shown).
To rule out the possibility that the recognition of HLA-A2 on the surface ofmu-
rine cells required the association of human R2-microglobulin (R2m) with the HLA-
A2 antigen, exchange ofhuman for the endogenous 02m was carried out on the mu-
rine EL4-A2 cell line. EL4-A2 was not lysed by any clone after this manipulation,
nor was any effect noted on lysis ofsimilarly treated human cell lines (Table III).
Discussion
The failure ofcertainhuman CTL specific for HLA class I molecules to recognize
thesemolecules when expressed on murine cells has been repeatedly observed(6-10).
Target HLA-A2 antigen
Percent-specific
Mean
S1Cr release
Range
23 .1 A2.1 80.6 65-96
310 A2.1 90.5 69-102
PBL A2.1 83.7 59-98
LA2 .1 A2.1 50.2 19-82
HMY2.CIR Negative 1 .3 -2-8
WT49 A2.2 0.7 -3-4
DKIB A2.3 4.0 1-17
DAUDI Negative -0.2 -4-4
MST Negative 3.1 0-14
JM Negative 3.0 -2-101160 BERNHARD ET AL.
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TABLE II
Recognition by HLA-A2.1-specific CTL Clones Derived
from HLA-A2 Transgenic Mice of Nonlymphoid Human
and Simian Target Cells
Specificity was determined at an E/T ratio of 10:1 . Reactivity was defined as
>10% specific lysis. Target cells included RDA2, a human rhabdomyosarcoma
cell line (HLA-Al, BW51,B14) transfected with the HLA-A2.1 gene and RD
mock, transfected with the neomycin resistance gene alone; MIA2.1 and MIA3.1,
HLA-A2.1 and HLA-A3.1-expressing transfectants ofthe MI human xeroder-
ma pigmentosum fibroblast line; 1436tk-, an HLA-A2-expressing human os-
teosarcoma line ; GM126, a human HLA-A2-expressing primary fibroblast;
GM2709, an HLA-A2-expressing lymphocyte, and GM2708, a primary fibro-
blast from the same donor; CVIP5A2 , an African green monkey kidney cell
line transfected with the HLA-A2.1 gene, and CV101 mock, transfected with
the neomycin-resistance gene alone; EL4-A2, an HLA-A2.1-expressing trans-
fectant of the murine thymoma cell line EL4, and the untransfected EL4 cell.
It has been suggested that this is due to an inability ofaccessorymolecules on human
CTL to bind to their ligands on murine target cells. However, it has also been ob-
served that certain murine CTL raised against HLA antigens expressed on human
cells fail to recognize these antigens on murine transfectants (4). This result cannot
readily beexplainedby alack ofparticipation ofaccessory molecules, since theCTL
and thetarget areofthe same species. It wasinsteadsuggested based on finespecificity
patterns that this phenomenon is due to differences in the HLA class I molecule
expressed onhuman andmurine cells(5, 11). The resultsofthisstudyprovide definitive
evidence for the existence ofone or more CTL-defined epitopes on the HLA-A2.1
molecule expressed on human cells, which are entirely absent from this molecule
when expressed on murine cells.
It is unlikely that these epitopes result from differences in post-translational
modification ofthe HLA-A2.1 molecule in human and murine cells, since no such
differences have been detected (6, 7). In addition, the carbohydrate side chain has
been shown not to influence CTL recognition ofclass I molecules (15-17). The rec-
ognition ofhuman HLA-A2.1-expressingcells from different individuals andtissues
also suggests that these epitopes do not arise from the association ofthe HLA-A2.1
moleculewith human minor histocompatibility or tissue-specific antigens. However,
the variable lysis ofthe 143bTK- osteosarcoma suggests that some of these epitopes
may be lost due to tissue-specific or tumor-specific alteration. It appears that these
CTL clones recognize epitopes formed by one or moreendogenous, highly conserved
but species specific molecules in the context ofHLA-A2.1. Given the demonstration
Target
Representative
ATl-3
clones
ATI-19
Number of clones
reactive with target
RDA2 58 44 23/23
RD mock - 1 - 5 0/23
MIA2.1 67 69 14/14
MIA3.1 4 3 0/14
GM126 29 24 11/11
GM2708 90 70 11/11
GM2709 62 43 11/11
143bTK- 19 17 17/22
CVlP5A2 - 1 52 3/23
CV 101 mock - 2 - 2 0/23
EL4-A2 0 - 2 0/23
EL4 2 3 0/23BERNHARD ET AL.
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TABLE III
The Epitopes Recognized by HLA-A2. I-specific CTL Clones
from HLA-A2 Transgenic Mice Are not Dependent upon
Human 132-Microglobulin
Target cells include the HLA-A2 .1-transfected cell lines LA2.1 (human) and
EL4-A2 (murine). Serum mediated 02m exchange was carried out with either
FCS or human serum (HuS) as described in Materials and Methods. The E/T
ratio was 25:1 .
that peptides may associate with class I molecules to form epitopes recognized by
CTL (2, 3, 18, 19), it is tempting to suggest that theseepitopes have a similar origin.
Thedata presentedhere raise the possibility that epitopes recognized by alloreactive
T cells may also result from the presentation of endogenously derived molecules
in association with a class I MHC molecule on the surface of the stimulator cell.
Summary
CTL clones were derivedfrom HLA-A2.1 transgenic mice by immunization with
ahuman cell expressing HLA-A2.1. None of these clones lysed murine transfectants,
and only 3 of 23 lysed monkey transfectants expressing HLA-A2. In contrast, all
oftheseclones lysed awide varietyofhumancells expressing HLA-A2.1. Theseresults
demonstrate the existence of species-specific epitopes on the HLA-A2.1 molecule,
and suggest that these epitopes are formed by the association of class I MHC prod-
ucts with one or more endogenous species-specific molecules. These resultsprovide
an explanation for the frequently observed failure of HLA class I-specific CTL to
recognizethese,antigens on murine transfectants. These results also suggest that such
endogenous proteins may also contribute to the formation of epitopes recognized
by allospecific CTL.
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